Date published: 2025-10-1

1-800-457-3801

SCBT Portrait Logo
Seach Input

MARCO Antibody (IBL-12): sc-65353

1.0(1)
Write a reviewAsk a question

Datasheets
  • MARCO Antibody (IBL-12) is a rat monoclonal IgG, cited in 2 publications, provided at 100 µg/ml
  • raised against Macrophage receptor with collagenous structure of mouse origin
  • recommended for detection of MARCO of mouse origin by IF and FCM
  • At present, we have not yet completed the identification of the preferred secondary detection reagent(s) for MARCO Antibody (IBL-12). This work is in progress.

QUICK LINKS

SEE ALSO...

MARCO Antibody (IBL-12) is a rat monoclonal IgG antibody that detects mouse MARCO by immunofluorescence (IF) and flow cytometry (FCM). Anti-MARCO antibody (IBL-12) is available in non-conjugated form. The macrophage receptor with collagenous structure (MARCO) plays a crucial role in the immune response, particularly in macrophage function, providing nonspecific defense against pathogens. MARCO is primarily located on macrophage surfaces, acting as a major receptor for binding both Gram-positive and Gram-negative bacteria, facilitating their clearance from the body. MARCO (IBL-12) antibody targets a receptor especially important in alveolar macrophages, helping maintain lung health by preventing bacterial infections. MARCO is involved in silica uptake, which can lead to cytotoxic effects in murine macrophages. Mutations in MARCO genes can result in increased pulmonary inflammation and cytokine release, highlighting MARCO′s significance in maintaining immune homeostasis and pathogen clearance from lungs. MARCO′s interaction with various pathogens underscores its importance in the innate immune system, making anti-MARCO antibody (IBL-12) valuable for studying macrophage function and immune responses in mouse models.

For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.

Alexa Fluor® is a trademark of Molecular Probes Inc., OR., USA

LI-COR® and Odyssey® are registered trademarks of LI-COR Biosciences

MARCO Antibody (IBL-12) References:

  1. Targeting MARCO and IL37R on Immunosuppressive Macrophages in Lung Cancer Blocks Regulatory T Cells and Supports Cytotoxic Lymphocyte Function.  |  La Fleur, L., et al. 2021. Cancer Res. 81: 956-967. PMID: 33293426
  2. Single-cell characterization of macrophages in glioblastoma reveals MARCO as a mesenchymal pro-tumor marker.  |  Chen, AX., et al. 2021. Genome Med. 13: 88. PMID: 34011400
  3. TLR2 Potentiates SR-Marco-Mediated Neuroinflammation by Interacting with the SRCR Domain.  |  Wang, L., et al. 2021. Mol Neurobiol. 58: 5743-5755. PMID: 34398403
  4. MARCO is a potential prognostic and immunotherapy biomarker.  |  Dong, Q., et al. 2023. Int Immunopharmacol. 116: 109783. PMID: 36773567
  5. UGRP1-modulated MARCO+ alveolar macrophages contribute to age-related lung fibrosis.  |  Chen, Y., et al. 2023. Immun Ageing. 20: 14. PMID: 36934284
  6. MARCO Inhibits Porcine Reproductive and Respiratory Syndrome Virus Infection through Intensifying Viral GP5-Induced Apoptosis.  |  Zhang, X., et al. 2023. Microbiol Spectr. 11: e0475322. PMID: 37078873
  7. Long-Chain Acyl Carnitines Aggravate Polystyrene Nanoplastics-Induced Atherosclerosis by Upregulating MARCO.  |  Wang, B., et al. 2023. Adv Sci (Weinh). 10: e2205876. PMID: 37144527
  8. Blocking MARCO+ tumor-associated macrophages improves anti-PD-L1 therapy of hepatocellular carcinoma by promoting the activation of STING-IFN type I pathway.  |  Ding, L., et al. 2024. Cancer Lett. 582: 216568. PMID: 38065400
  9. The application of MARCO for immune regulation and treatment.  |  Zhou, G., et al. 2024. Mol Biol Rep. 51: 246. PMID: 38300385
  10. The co-location of MARCO+ tumor-associated macrophages and CTSE+ tumor cells determined the poor prognosis in intrahepatic cholangiocarcinoma.  |  Fan, G., et al. 2024. Hepatology.. PMID: 39471066

Ordering Information

Product NameCatalog #UNITPriceQtyFAVORITES

MARCO Antibody (IBL-12)

sc-65353
100 µg/ml
$316.00